Godfraind C - Search Results

1

DNA alteration-based classification of uveal melanoma gives better prognostic stratification than immune infiltration, which has a neutral effect in high-risk group.

Narasimhaiah D, Legrand C, Damotte D, Remark R, Munda M, De Potter P, Coulie PG, Vikkula M, Godfraind C. Narasimhaiah D, et al. Among authors: godfraind c. Cancer Med. 2019 Jun;8(6):3036-3046. doi: 10.1002/cam4.2122. Epub 2019 Apr 25. Cancer Med. 2019. PMID: 31025552 Free PMC article.

2

Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis.

Palm T, Figarella-Branger D, Chapon F, Lacroix C, Gray F, Scaravilli F, Ellison DW, Salmon I, Vikkula M, Godfraind C. Palm T, et al. Among authors: godfraind c. Cancer. 2009 Sep 1;115(17):3955-68. doi: 10.1002/cncr.24476. Cancer. 2009. PMID: 19536879 Free article.

3

IDH1 mutation, a genetic alteration associated with adult gliomatosis cerebri.

Narasimhaiah D, Miquel C, Verhamme E, Desclée P, Cosnard G, Godfraind C. Narasimhaiah D, et al. Among authors: godfraind c. Neuropathology. 2012 Feb;32(1):30-7. doi: 10.1111/j.1440-1789.2011.01216.x. Epub 2011 Apr 11. Neuropathology. 2012. PMID: 21481010

4

A novel mutation in the SDHD gene in a family with inherited paragangliomas--implications of genetic diagnosis for follow up and treatment.

Renard L, Godfraind C, Boon LM, Vikkula M. Renard L, et al. Among authors: godfraind c. Head Neck. 2003 Feb;25(2):146-51. doi: 10.1002/hed.10220. Head Neck. 2003. PMID: 12509798

5

Trisomy 19 ependymoma, a newly recognized genetico-histological association, including clear cell ependymoma.

Rousseau E, Palm T, Scaravilli F, Ruchoux MM, Figarella-Branger D, Salmon I, Ellison D, Lacroix C, Chapon F, Mikol J, Vikkula M, Godfraind C. Rousseau E, et al. Among authors: godfraind c. Mol Cancer. 2007 Jul 12;6:47. doi: 10.1186/1476-4598-6-47. Mol Cancer. 2007. PMID: 17626628 Free PMC article.

6

Embryonal rhabdomyosarcoma presenting as conjunctival tumor.

Brichard B, De Potter P, Godfraind C, Vermylen C. Brichard B, et al. Among authors: godfraind c. J Pediatr Hematol Oncol. 2003 Aug;25(8):651-2. doi: 10.1097/00043426-200308000-00014. J Pediatr Hematol Oncol. 2003. PMID: 12902922

7

Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB.

Uebelhoer M, Nätynki M, Kangas J, Mendola A, Nguyen HL, Soblet J, Godfraind C, Boon LM, Eklund L, Limaye N, Vikkula M. Uebelhoer M, et al. Among authors: godfraind c. Hum Mol Genet. 2013 Sep 1;22(17):3438-48. doi: 10.1093/hmg/ddt198. Epub 2013 Apr 30. Hum Mol Genet. 2013. PMID: 23633549 Free PMC article.

8

Somatic Activating PIK3CA Mutations Cause Venous Malformation.

Limaye N, Kangas J, Mendola A, Godfraind C, Schlögel MJ, Helaers R, Eklund L, Boon LM, Vikkula M. Limaye N, et al. Among authors: godfraind c. Am J Hum Genet. 2015 Dec 3;97(6):914-21. doi: 10.1016/j.ajhg.2015.11.011. Am J Hum Genet. 2015. PMID: 26637981 Free PMC article.

9

Primary orbital melanoma treated with iodine-125 plaque radiotherapy.

De Potter P, Levecq L, Godfraind C, Renard L. De Potter P, et al. Among authors: godfraind c. Am J Ophthalmol. 2006 Nov;142(5):864-6. doi: 10.1016/j.ajo.2006.05.050. Am J Ophthalmol. 2006. PMID: 17056373

10

Choroidal metastasis from carcinoma of the bladder.

Levecq L, De Potter P, Godfraind C, Guagnini AP, Kozyreff A. Levecq L, et al. Among authors: godfraind c. Retin Cases Brief Rep. 2007 Fall;1(4):251-3. doi: 10.1097/01.iae.0000231355.25528.6d. Retin Cases Brief Rep. 2007. PMID: 25390994

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters